MAPT and Alzheimer disease: We performed micro-X-PCI-CT to nano-X-PCI-CT and X-ray fluorescence microscopy on extracted brain samples from aged wild-type (WT) and triple-transgenic 3xTgAD mice [30], an experimental AD model that develops both amyloid and tau pathology [31].